Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 36.08 and traded as low as GBX 32.05. Cambridge Cognition shares last traded at GBX 32.05, with a volume of 60,992 shares changing hands.
Cambridge Cognition Price Performance
The company has a debt-to-equity ratio of 29.16, a current ratio of 0.40 and a quick ratio of 0.96. The firm’s 50 day simple moving average is GBX 34.14 and its two-hundred day simple moving average is GBX 36.08. The firm has a market capitalization of £17.25 million, a P/E ratio of -8.22 and a beta of 0.81.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Articles
- Five stocks we like better than Cambridge Cognition
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
